ABSTRACT A gene for calf prochymosin (prorennin) has been reconstructed from chemically synthesized oligodeoxyribonucleotides and cloned DNA copies of preprochymosin mRNA. This gene has been inserted into a bacterial expression plasmid containing the Escherichia coli tryptophan promoter and a bacterial ribosome binding site. Induction of transcription from the tryptophan promoter results in prochymosin synthesis at a level of up to 5% of total protein. The enzyme has been purified from bacteria by extraction with urea and chromatography on DEAE-celiulose and converted to enzymatically active chymosin by acidification and neutralization. Bacterially produced chymosin is as effective in clotting milk as the natural enzyme isolated from calf stomach.
Chymosin (rennin) is an aspartyl proteinase found in the fourth stomach of the unweaned calf, where it is responsible for limited proteolysis of K-casein in milk (1) , resulting in clotting (2) . Full-length cDNA copies of the mRNA for chymosin have recently been cloned and their sequences have been determined (3) (4) (5) . The primary translation product of the mRNA is a precursor protein, preprochymosin, that has a 16-amino acid leader peptide. This signal sequence is removed to produce the zymogen prochymosin, which in turn is converted to active chymosin under the acid conditions of the stomach by removal of the 42-amino acid propeptide from the NH2-terminus (6) .
Recombinant plasmids containing the preprochymosin coding sequence provided a choice of genes for expression in Escherichia coli-i.e., preprochymosin, prochymosin, or chymosin. Preprochymosin and chymosin were ruled out for the following reasons. For preprochymosin, the E. coli cell would have to recognize the eukaryotic signal peptide and process it accurately to prochymosin, which would then be found in the periplasmic space. Despite the fact that E. coli processes the rat preproinsulin gene in this manner (7), it does not, apparently, process preinterferon-a (8), preinterferon-f3 (9) , or pregrowth hormone (10) in the same way. Direct expression of the chymosin gene would be expected to lead, by analogy with human growth hormone (11) , to production of chymosin containing an additional methionine residue at the NH2 terminus ([Met]chymosin). Apart from possible deleterious effects of the production of active chymosin in E. coli, there was also the possibility that an NH2-terminal methionine would alter the activity or tertiary structure of the enzyme. The expression of prochymosin, on the other hand, offered positive advantages. First, the 42-amino acid propeptide can be removed in vitro by acidification followed by incubation at pH 6 (12) and, assuming that a [Met]prochymosin could be cleaved in similar fashion, the product would be authentic chymosin rather than [Met]chymosin. Second, since preliminary experiments indicated that the majority of E. coli proteins (about 90%) precipitated under the acidic chymosin
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We describe here the construction of E. coli plasmids de- (17) and treated with DNase (18) . The resulting suspension was centrifuged at 10,000 x g for 30 min at 4°C, the pellet formed was suspended in 300 ml of 50 mM Tris HCI, pH 8/0.1 M NaCI/ 1 mM EDTA and recentrifuged as above. Washed cell debris was dissolved in 200 ml of 9 M urea (freshly deionized)/50 mM Tris HCI, pH 8/0.5 M NaCI/1 mM EDTA and dialyzed overnight at 40C against 5 liters of 50 mM Tris'HCI, pH 8/0.5 M NaCI/1 mM EDTA/10% (vol/vol) glycerol. The suspension was centrifuged as above, and the supernatant diluted 1:4 with 0.01 M Tris HCI, pH 8/1 mM EDTA/10% (vol/vol) glycerol and applied to a 200-ml column (4.7 x 15 cm) of DEAE-cellulose previously washed and equilibrated in 0.01 M Tris HCI, pH 8/ 1 mM EDTA/10% (vol/vol) glycerol. Adsorbed proteins were eluted with a linear gradient of NaCl (0.05-0.5 M) in equilibration buffer. Prochymosin-containing fractions were detected by assaying activated samples for milk-clotting activity and by NaDodSO4/polyacrylamide gel electrophoresis of fractions across the profile. The enzyme eluted reproducibly as a single peak at a NaCl concentration of 0.25 M. Appropriate prochymosin fractions with a purity at this stage of approximately 50% were pooled and activated as described above to generate chymosin. The insoluble protein impurities generated by acidification were removed by centrifugation and pure chymosin was stored at -20'C. Further details of the isolation of chymosin from E. coli will appear elsewhere.
RESULTS AND DISCUSSION
Construction of the Prochymosin Gene. The approach used for the bacterial synthesis of [Met]prochymosin was to reconstruct a gene in vitro from restriction fragments of a cDNA clone and then use synthetic DNA fragments for insertion into a bacterial plasmid immediately downstream from the strong E. coli trp promoter, a functional ribosome binding site and ATG. As shown in Fig. 1A , a BamHI restriction site is conveniently located between codons 5 and 6 of the prochymosin sequence. Two oligodeoxyribonucleotides were designed to restore codons 1-6 and produce a blunt 5' end with a 5'-OH group. These oligomers were hybridized and ligated to the 474-base-pair (bp) BamHI fragment from plasmid 118 (3) and the resulting DNA was cleaved with EcoRI to produce a 478-bp DNA fragment coding for the 5' end of prochymosin. Proc. Natl. Acad. Sci. USA 80 (1983) at this end in subsequent reactions. The 5'-and 3'-end fragments were recombined through the EcoRI cohesive ends and ligated by using T4 DNA ligase. The reconstructed prochymosin gene of 1,250 bp was isolated by gel electrophoresis after phosphorylation of the 5' ends by using polynucleotide kinase.
Construction of the Prochymosin Expression Vector. The vector designed for the expression of prochymosin was pCT54 (Fig. 1C) , which contains the E. coli trp promoter, operator, and leader ribosome binding site (19) . In addition, 14 nucleotides downstream of the ribosome binding site is an initiator ATG followed immediately by EcoRI and HindIII sites and the terminator for E. coli RNA polymerase from bacteriophage T7 (20) . This plasmid was digested with EcoRI and treated with nuclease S1 to generate a blunt end directly after the ATG; a fragment (A in Fig. 1C ) containing the tip promoter and trp leader ribosome binding site was prepared by Sal I digestion and polyacrylamide gel electrophoresis. A second fragment (B in Fig. 1C) (14) and digesting with BamHI. The sequences of eight plasmids producing the predicted fragment pattern were determined from the Cla I site (23). All eight plasmids had the same sequence; that of pCT66 is shown in Fig. 1 . Expression of the Prochymosin Gene. E. coli cells containing pCT66 were tested for expression of prochymosin. Because transcription from the tip promoter is induced by lack of tryptophan in the medium, cells were grown in minimal medium to late exponential phase and total cellular extracts were prepared and subjected to electrophoresis on NaDodSO4/poly- before and after activation were assayed-4, pCT54-derived extract before activation; 5, as in row 4 but after activation; 6, pCT70-derived extract before activation; 7, a 1:4 dilution of the enzyme used in row 6 after activation; 8, a 1:12 dilution of the enzyme used in row 6 after activation. Rows 9-12: E. coli-derived chymosin purified by DEAEcellulose chromatography was compared with calf chymosin for susceptibility to protease inhibitors (inhibitor solutions were serially diluted: pepstatin A, 228-1.8 ,M;phenylmethylsulfonyl fluoride, 2,850-22 tM)-9, calf chymosin with pepstatin A; 10 (24) . No new protein band comigrating with authentic prochymosin was observed. Part of the rationale in constructing pCT54 was the inclusion of two restriction sites (Bcl I and Cla I) between the Shine-Dalgarno sequence (A-A-G-G) and the ATG sp that the distance between these sequence elements could be varied. As most E. coli mRNAs have 6-11 nucleotides between the Shine-Dalgarno sequence and the AUG (25), the distance in pCT66 (14 nucleotides) was reduced by modification at the Cla I site. Thus, pCT66 was cleaved with Cla I and incubated with nuclease S1 to remove the C-G sticky ends, and the plasmid was religated. After transformation several ampicillin-resistant colonies, from a total of 700, were selected and grown overnight in L broth. A 10-pul aliquot of each was inoculated into 1 ml of M9 medium containing glucose, casamino acids, and ampicillin (100 ,ug/ml) and grown for 3 hr at 37TC. Bacteria were harvested and lysed in sample buffer, and the proteins were subjected to electrophoresis on a NaDodSO4/polyacrylamide gel together with a sample of purified prochymosin. The majority of clones produced a new band on induction that comigrated with the authentic prochymosin standard. The nucleotide sequence across the modified region of two of these plasmids was determined (Fig. 1D ). pCT67 and pCT70 were shorter than pCT66 by two and three nucleotides, respectively, giving Shine-Dalgarno-to-ATG distances of 12 and 11 nucleotides. Removal of these nucleotides by nuclease S1 may promote expression of the prochymosin gene by relieving asecondary structure constraintin the mRNA (26) or, more likely, by placing the Shine-Dalgarno sequence and the ATG in the optimal configuration for formation of the initiation complex (27) .
A polyacrylamide gel showing [3S]methionine-labeled proteins from E. coli containing pCT70 or pCT54 after induction is shown in Fig. 2A (lanes 1 and 3) . A (Fig.  2B ) by gel scanning indicated that, depending on fermentation conditions, 1-5% of total E. coli protein was expressed as prochymosin, equivalent to 50,000-250,000 molecules per cell. After cell lysis and centrifugation, prochymosin was detected in the cell debris by both NaDodSO4/polyacrylamide gel electrophoresis and immunoprecipitation, indicating that the protein accumulates in an insoluble or aggregated form. The presence of prochymosin in the pellet fraction, however, was a useful purification step because it both concentrated the protein and separated it from the bulk of E. coli soluble proteins. For further purification, prochymosin was solubilized with a buffer containing 9 M urea, the urea was subsequently removed by dialysis, and the soluble enzyme was isolated by DEAE-cellulose chromatography followed by acidification. These steps removed most contaminating E. coli proteins and simultaneously generated chymosin (Fig. 2B, lanes 7, 8, and 9) .
Characterization of Chymosin. The clotting activity of chymosin derived from E. coli containing pCT70 is compared with that of calf chymosin in Fig. 3 . Both the E. coli and calf zymogens are inactive and require acidification for the generation of clotting activity. The enzyme is present in E. coli containing pCT70 but absent from cells harboring pCT54 (Fig. 3, rows 4-8) . The clotting activity of both the E. coli and calf enzymes is sensitive to pepstatin, the specific inhibitor of aspartyl proteinases (30) , and insensitive to phenylmethylsulfonyl fluoride, the inhibitor of serine proteinases (Fig. 3, rows 9-12) . Furthermore, the specific activity of highly purified chymosin isolated from E. coli was similar to that of calf chymosin in the milkclotting assay. It is therefore concluded that pCT70 expresses prochymosin, which can be solubilized, purified, and acid matured to produce the milk-clotting enzyme chymosin.
In conclusion, the results presented here show that biologically active enzymes expressed from eukaryotic genes can be produced in E. coli. Although several eukaryotic enzymes have been expressed in E. coli before-e.g., dihydrofolate reductase (31, 32) , urokinase (33), Rous sarcoma virus src protein kinase (34, 35) , and herpes simplex virus thymidine kinase (36, 37)-they have generally been made at low levels or in a modified form as fusion proteins or the products have not been purified. This, therefore, represents one of the few reports of the synthesis, purification, and characterization of a eukaryotic enzyme in E. coli. Further, this work provides a basis for the development of a process for the production of chymosin from E. coli. This process or one based on expression of the preprochymosin or prochymosin gene in Saccharomyces cereviiae may ultimately provide an alternative source of chymosin for the cheese-making industry to compensate for the present shortage caused by a reduction in the veal calf market.
